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Abstract
Prenatal supplementation with protein‐energy (PE) and/or multiple‐micronutrients (MMNs) may
improve fetal growth, but trials of lipid‐based nutritional supplements (LNSs) have reported
inconsistent results. We conducted a post‐hoc analysis of non‐primary outcomes in a trial in
Gambia, with the aim to test the associations of LNS with fetal growth and explore how efficacy
varies depending on nutritional status. The sample comprised 620 pregnant women in an individ-
ually randomized, partially blinded trial with four arms: (a) iron and folic acid (FeFol) tablet (usual
care, referent group), (b) MMN tablet, (c) PE LNS, and (d) PE + MMN LNS. Analysis of variance
examined unadjusted differences in fetal biometry z‐scores at 20 and 30 weeks and neonatal
anthropometry z‐scores, while regression tested for modification of intervention‐outcome asso-
ciations by season and maternal height, body mass index, and weight gain. Despite evidence of
between‐arm differences in some fetal biometry, z‐scores at birth were not greater in the inter-
vention arms than the FeFol arm (e.g., birth weight z‐scores: FeFol −0.71, MMN −0.63, PE −0.64,
PE + MMN −0.62; group‐wise p = .796). In regression analyses, intervention associations with
birth weight and head circumference were modified by maternal weight gain between booking
and 30 weeks gestation (e.g., PE + MMN associations with birth weight were +0.462 z‐scores
(95% CI [0.097, 0.826]) in the highest quartile of weight gain but –0.099 z‐scores (−0.459,
0.260) in the lowest). In conclusion, we found no strong evidence that a prenatal LNS interven-
tion was associated with better fetal growth in the whole sample.
KEYWORDS
fetal growth, gestational weight gain, lipid‐based nutritional supplement, randomized control trial,
seasonality, The Gambia
1 | INTRODUCTION
In the 2013 Maternal and Child Nutrition series in the Lancet, Black
et al. (2013) estimated that undernutrition in the aggregate was
responsible for 45% of child mortality, with fetal growth restriction
alone accounting for 12% of deaths. This series also included a com-
prehensive review of nutritional interventions which concluded,
among other things, that balanced prenatal protein‐energy (PE) and
multiple‐micronutrient (MMN) supplementation could potentially
reduce fetal growth restriction and thus the risk of small‐for‐gesta-
tional age (SGA) birth (Bhutta et al., 2013). This finding is in line with
the most recent Cochrane reviews (Haider & Bhutta, 2015; Ota, Hori,
Mori, Tobe‐Gai, & Farrar, 2015). Given the adverse consequences of
SGA for mortality (Katz et al., 2013), and its links through postnatal
growth failure with a wide range of health and human capital outcomes
(Adair et al., 2013; Christian et al., 2013), there is a clear need to under-
stand which routes of prenatal nutritional supplementation are most
effective and in whom.
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Recently developed lipid‐based nutritional supplements (LNSs),
which are affordable, safe, can be produced locally, and have a long
shelf‐life, have been shown to be a very effective option for the
community‐based treatment of severe malnutrition if a high dose
is given (Briend & Collins, 2010; Tekeste, Wondafrash, Azene, &
Deribe, 2012; WHO, 2007). They may also provide a route of
MMN delivery that may be more preferable and efficacious than
other products. A trial in Ghanaian infants, for example, found that
LNS fortified with MMN had a positive effect on some growth and
motor development outcomes compared to two other types of
MMN supplements (Sprinkles powder and crushable Nutritabs) for
home fortification of complementary foods (Adu‐Afarwuah, Lartey,
Brown, Zlotkin, & Dewey, 2007). Few trials have given LNS to
pregnant women, and their results have been equivocal. One study
in Malawi found no strong evidence of an effect on birth size of a
small‐quantity‐LNS product (SQ‐LNS 118 kcal/day) fortified with
MMN compared to either an iron and folic acid (FeFol) arm or a
MMN arm (Ashorn et al., 2015). Whereas, a study in Bangladesh
reported significant effects of fortified SQ‐LNS (118 kcal/day) com-
pared to a FeFol arm on a range of birth size outcomes, including
stunting (relative risk 0.83; 95% confidence interval (CI) [0.71,
0.97]); this effect of SQ‐LNS on reduced stunting risk was strongest
in women aged ≤24 years or with household food insecurity
(Mridha et al., 2016). Further, one study in Ghana reported signifi-
cant effects of fortified SQ‐LNS (118 kcal/day) compared to a
MMN only arm on birth weight (+139 g; 6, 272) and birth length
(+6.7 mm; 0.6, 12.7) only among the sub‐group of primiparous
women (Adu‐Afarwuah et al., 2015), and one study in Burkina Faso
reported significant effects of fortified LNS (372 kcal/day) com-
pared to a MMN only arm on birth length (+13.5 mm; 6.5, 20.5)
only among birth occurring at the end of the nutritionally debilitat-
ing rainy season (Huybregts et al., 2009; Toe et al., 2015). The lat-
ter finding is in agreement with previous work from our group in
rural Gambia, where we found that a daily high‐energy ground‐nut
biscuit supplement providing approximately 1000 kcal/day of
energy increased birth weight by 94 g (31, 157) for births occurring
in the dry season but by 201 g (132, 270) for births occurring in
the rainy season (Ceesay et al., 1997).
It appears that fortified LNS may impact on fetal growth and
development most among women who are more nutritionally vulnera-
ble; rural Gambian women represent one such group, especially during
the rainy season (Poppitt, Prentice, Goldberg, & Whitehead, 1994;
Poppitt, Prentice, Jequier, Schutz, & Whitehead, 1993; Prentice,
Whitehead, Roberts, & Paul, 1981; Rayco‐Solon, Fulford, & Prentice,
2005). The existing literature has focused on anthropometry taken at
birth as a proxy for total fetal growth, but investigation using fetal
biometry measures would provide a more dynamic picture and allow
quantification of the ages in development when supplementation
might first start to affect growth. The aim of the present study was
to conduct a post‐hoc analysis, in a prenatal LNS trial with fetal biom-
etry starting early in gestation (as well as neonatal anthropometry), to
test the associations of LNS with fetal growth. Further, we explored
how efficacy of the interventions might vary depending on season
and, associated to this, mothers' nutritional status.
2 | PARTICIPANTS AND METHODS
2.1 | Sample
The sample comprised 620 mothers and their singleton offspring (304
males; 316 females) enrolled in the early nutrition and immune devel-
opment trial (ENID; trial registration: ISRCTN49285450) in rural
Gambia. As shown in Supplementary Figure 1, the sample for the pres-
ent paper was selected from the total ENID sample (N = 875) based on
the offspring being live births with complete birth weight and gesta-
tional age data. Defining characteristics were not different between
this sample and those ENID participants who did not meet the inclu-
sion criteria (N = 875–620 = 255). For example, where data were avail-
able, the comparison was 162.0 versus 61.7 cm (p = .442) for maternal
height at booking, 29.6 versus 29.9 years for maternal age at booking
(p = .642), and 37.9 versus 38.7 for the percentage of births occurring
in the raining season (p = .861).
2.2 | Study design and intervention
The ENID trial has been described in detail elsewhere (Moore et al.,
2012), but briefly is a randomized, partially blind trial to assess whether
or not nutritional supplementation to pregnant women (from
<20 weeks gestation to term) and their infants (from 6 to 12 months
of age) can enhance immune development. Pregnancies were identi-
fied through monthly surveillance in all eligible non‐pregnant women
of reproductive age (18–45 years) in the West Kiang region of The
Gambia; date of last menstrual period was assessed, and a urine test
was conducted if a menstrual period was missed. Women confirmed
by ultrasound as being between 10 and 20 weeks pregnant at a clinic
Key messages
• Improving pregnant women's diet with LNS did not significantly increase offspring birth weight, length, and head circumference in
rural Gambia in the whole sample.
• In sub‐group analyses, however, positive and significant associations of all interventions with birth weight and head circumference
were observed among women who demonstrated the greatest gestational weight gain.
• Further investigation is needed to understand whether or not, which, and how environments conducive to better gestational weight
gain allow LNS to be utilized by the mother to support fetal growth in resource poor settings.
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booking visit were randomized to one of four arms: (a) FeFol, (b) MMN,
(c) PE, and (d) PE + MMN.
Supplementation commenced the following week, with the first
two arms receiving daily tablet supplements and the latter two arms
receiving daily LNS. Both supplement types (tablets and LNS) were
distributed on a weekly basis to participating women. Women were
supplied with 14 tablets per week in individual bottles and advised
to take two tablets per day, preferably with food. LNS were supplied
in jars, with a single (daily) dose per jar. Women were encouraged to
consume the whole jar each day, with the option of eating it straight
from the jar (spoons were supplied) or eating it with food. Given the
common practice of sharing from a family bowl, women were
encouraged to take a separate portion of the food from the family
bowl and mix the LNS into that. The first women started to receive
supplementation in January 2010, and the final infant was born in
February 2014. Compliance was assessed through the collection of
all unused supplements at the end of each week. For tablets, a count
on remaining tablets was performed, and for LNS products, a score
based on the amount of supplement left remaining in the jar was
made (empty, half‐empty, and full). A compliance percentage was
computed for each woman by dividing the number of LNS pots or
tablets the woman consumed by the number she was offered, and
multiplying by 100.
The nutritional composition of the intervention products is detailed
in the study protocol published by Moore et al. (2012). Briefly, all arms
received the Gambian government guidelines for iron (60 mg/day) and
folic acid (400 μg/day) supplementation during pregnancy. The two
arms also receiving MMN were additionally provided with two times
the UNICEF/World Health Organization (WHO)/United Nations Uni-
versity formulation of key micronutrients, and the two arms also receiv-
ing PE were additionally provided with 746 kcal/day of energy from
protein and lipids.
From 6 to 12 months of age, infants were further randomized to a
LNS supplement, with or without additional MMN, but this second
randomization stage does not need to be considered for the purposes
of the present paper as our focus is on fetal growth.
2.3. Ethics
The trial was approved by the joint Gambia Government/MRC Unit,
The Gambia Ethics Committee (Project number SCC1126v2). Written
informed consent was obtained from all women prior to enrolment
into the trial. The trial observed Good Clinical Practice Standards and
the current version of the Helsinki Declaration. The trial was registered
as ISRCTN49285450.
2.4. Measurements
This paper uses data from the clinic enrolment or “booking” visit, sub-
sequent clinic visits at 20 and 30 weeks of gestation, and a home visit
performed within 72 hr of birth.
FIGURE 1 Flow diagram of sample selection
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2.4.1. Fetal biometry
At the three prenatal clinic visits, fetal biometry was assessed via
ultrasound using a Siemens ACUSON Antares Ultrasound Imaging
System (Siemens Medical Solutions United States of America (USA)
Inc; California, USA with a CH6–2 (5.71 MHz) transducer). Using the
built‐in equations, the purpose of the fetal biometry measurements
taken at booking was to estimate gestational age. This estimation was
based on crown‐rump length (CRL) if gestational age was <12 weeks,
or bi‐parietal diameter (BPD) if CRL was too large to be accurately mea-
sured or gestational age was ≥12weeks. If CRLwas not yet measurable,
gestational age was estimated according to the size of the gestational
sac, and the woman's booking visit was rescheduled for 12 weeks ges-
tation. Subsequently, at the 20 and 30 week visits measurements of
femur length (FL), head circumference (HC), occipital‐frontal diameter
(OFD), and abdominal circumference (AC), as well at BPD were
performed using standard methods (Meire & Farrant, 1995; O'Brien &
Queenan, 1981). These measurements were taken on each fetus at
each visit by one of two sonographers, who were blind to women's
the allocation group. Prior to the start of the study, the two
sonographers were trained in fetal biometry, and their measures were
standardized according to the protocols as detailed and published by
Neufeld, Wagatsuma, Hussain, Begum, and Frongillo (2009). Standard-
ization exercises were performed for each outcome measure at each
time point until a level of inter‐ and intra‐observer reliability deemed
acceptable by the trainer was reached.
2.4.2. Neonatal anthropometry
Neonatal anthropometry was performed in the infant's home, by the
study midwife and within 72 hr of delivery. Weight was measured
using digital infant scales (Seca mobile digital babyscale 334; UK) with
the infant in minimal clothing and to the nearest 10 g. Length was mea-
sured on a portable infant rollameter (Rollameter 100; Harlow
Healthcare, UK) to the nearest 0.1 cm. HC was measured using stan-
dard circumference tapes (Seca; UK). All measures were made using
standard protocols, and equipment was regularly validated.
2.4.3. Maternal factors
Maternal weight and height were measured at the booking and 20
and 30 week visits using standard techniques and equipment (Tanita
DH305 scales [Tanita Corporation; Japan] and Leicester height mea-
sure [Seca 214; UK]). Maternal date of birth and thus age at book-
ing were ascertained from the West Kiang Demographic
Surveillance System (Hennig et al., 2015). Maternal parity was com-
puted, using questionnaire data collected at booking, as the number
of deliveries (i.e., alive children, dead children, and still births)
excluding abortions.
2.5. Statistics
All fetal biometry and maternal and neonatal anthropometry variables
were measured in triplicate, and here, we used the median across the
three recordings. To account for small differences in timing of
assessment and enable comparison across the different measures, fetal
biometry were converted to z‐scores according to the INTER-
GROWTH‐21st standard (Papageorghiou et al., 2014), and neonatal
anthropometry were converted to z‐scores according to the WHO
child growth standard (WHO Multicentre Growth Reference,Study
Group, 2006). Further, low birth weight was defined as birth weight
<2.5 kg, SGA as weight‐for‐gestational age <10th percentile of the
INTERGROWTH‐21st standard (Villar et al., 2014), and preterm as a
gestational age at birth <37 0/7 weeks. Maternal body mass index
(BMI) at booking was computed as weight (kg)/height (m)2. Maternal
weight gain variables from booking to 20 weeks, booking to 30 weeks,
and 20 to 30 weeks, were calculated and expressed as kg per week.
Analyses using standardized residual measures that account for regres-
sion to the mean produced similar results (Keijzer‐Veen et al., 2005), so
we only present results using the simpler and easier to interpret mea-
sures. Given the focus of the present paper, season of assessment was
not modeled using Fourier terms (Fulford, Rayco‐Solon, & Prentice,
2006) but instead was approximated using binary variables (November
to May = dry or June to October = rainy).
Descriptive statistics for baseline variables were produced, strati-
fied by intervention arm. Unadjusted between‐arm differences in pri-
mary and secondary outcomes were tested using analysis of variance
or Kruskal–Wallis for continuous variables and chi‐squared tests for
categorical variables.
General linear regression models were used to test whether or
not intervention associations (i.e., MMN, PE, or MMN + PE vs. FeFol)
with fetal biometry (FL, HC, BPD, OFD, and AC) and neonatal anthro-
pometry (weight, length, HC, and weight‐for‐length [WFL]) Z‐scores
were modified by the following a priori specified variables: season
of assessment, maternal height and BMI at booking, and maternal
weight gain from booking. These variables were chosen based on evi-
dence from previous publications that fortified LNS may impact on
fetal growth and development most among women who are more
nutritionally vulnerable (Mridha et al., 2016; Adu‐Afarwuah et al.,
2015; Huybregts et al., 2009; Toe et al., 2015). For each combination
of the continuous outcomes and the potential modifiers, a model was
built including linear intervention‐by‐potential modifier terms. If at
least one of the corresponding p‐values was <.05 or if there was evi-
dence of association modification for the other dimensions assessed
at that visit, subsequent models stratified according to the modifier
were built. These stratified models were adjusted for sex, gestational
age and season at assessment, maternal height and BMI at booking,
and maternal weight gain from booking (i.e., booking to 20 weeks
for the 20 week models and booking to 30 weeks for the 30 week
and birth models); neonatal anthropometry models additionally
included age at assessment and parity. Given our sample size and
the hypothesised association modification, logistic models for binary
outcomes (e.g., SGA) were not performed because of the reduced
power this approach provides.
To investigate if compliance or length of time on supplement were
affecting the efficacy of the intervention, sensitivity analyses were
performed removing individuals in the bottom quartile of compliance
(standardized within each arm) or length of time on supplement. Fur-
ther, given that the majority of exclusions were due to missing birth
weight (N = 129), analyses were rerun using neonatal anthropometry
from a week one visit instead of the birth visit.
All analyses were performed in Stata 14 (StataCorp LP; College
Station, Texas, USA).
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3 | RESULTS
Baseline characteristics of the study sample, stratified according to
intervention arm, are shown in Table 1. Maternal variables (e.g., age,
weight, height, gestational age, and parity) were similar across the
fours arms, but mean fetal BPD was larger in the PE arm (30.2 mm)
compared to the other arms (28.5–29.8 mm).
3.1. Primary outcomes
The key findings are summarized in Table 2. There was limited evi-
dence that the supplements had affected fetal growth by 20 weeks
of gestation, with the exception that fetal biometry measures were
consistently greater in the PE arm compared to the other arms, with
group‐wise comparisons for FL and AC being significant (e.g., FL z‐
scores: FeFol −0.29, MMN −0.28, PE +0.13, PE + MMN −0.22;
group‐wise p = .012). A similar pattern was observed at 30 weeks of
gestation, but for different biometry measures (e.g., HC z‐scores: FeFol
−0.42, MMN −0.58, PE −0.18, PE + MMN −0.39; group‐wise p = .010).
Despite this evidence of between‐arm differences in some fetal biom-
etry measures, likely due to higher values in the PE group, neonatal
anthropometry z‐scores were not greater in the intervention arms than
the FeFol arm (e.g., birth weight z‐scores: FeFol −0.71, MMN −0.63, PE
−0.64, PE + MMN −0.62; group‐wise p = .796).
3.2. Secondary outcomes
On average, births occurred at an earlier gestational age in the PE
arm compared to the other arms (FeFol 40.1, MMN 40.4, PE 39.8,
PE + MMN 40.3; group‐wise p = .016), although were no
between‐arm differences in rates of preterm, low birth weight, and
SGA (Table 2). There were also no between‐arm differences in
maternal weight gain, which suggests that the nutritional
supplements were not being utilized by the mother herself for
greater gestational weight gain.
3.3. Association modification
Table 3 presents intervention‐by‐potential modifier estimates from 56
separate models. There was no evidence that maternal height or BMI
at booking modified any of the intervention associations with the out-
comes, but there was evidence that some of the interventions were
less efficacious in the wet season compared to the dry season for some
outcomes at 30 weeks gestation. For example, the association of
MMN (relative to FeFol) with OFD was 0.482 (95% CI [−0.955,
−0.009]) z‐scores lower if assessment occurred in the wet season com-
pared to the dry season. Accordingly, in the stratified analyses
presented in Table 4, estimates were generally larger/positive for the
sub‐group measured in the dry season and smaller/negative for the
sub‐group measured in the rainy season. Similarly, some interven-
tion‐by‐maternal weight gain terms were positive and significant in
the neonatal anthropometry models in Table 3, suggesting that the
interventions were more efficacious among women with greater gesta-
tional weight gain. Indeed, in the stratified analyses presented in
Table 4, all of the supplements had significant positive associations
with birth weight z‐scores among mothers who were in the highest
quartile of maternal weight gain (e.g., PE + MMN estimate = + 0.462;
0.097, 0.826) but not among those who were in the lowest quartile
(e.g., PE + MMN estimate = −0.099; −0.459, 0.260). Similar evidence
of association modification by maternal weight gain was observed for
HC and WFL, but not length z‐scores.
Nearly identical results to those presented in this paper were
obtained (a) in analyses restricted to individuals in the top three quar-
tiles of compliance (standardized within each arm) or length of time on
supplement and (b) in analyses using neonatal anthropometry from a
week one visit instead of the birth visit (data not presented).
TABLE 1 Baseline characteristics of study sample, by intervention arm
Tablets LNS
FeFol MMN PE PE + MMN
N = 146 N = 164 N = 151 N = 159
Gestational age (weeks) Mean (SD) 13.9 (3.4) 13.9 (3.4) 13.8 (3.3) 13.4 (3.2)
Bi‐parietal diameter (mm) (N = 194 missing) Mean (SD) 29.6 (9.5) 29.8 (9.8) 30.2 (9.6) 28.5 (8.9)
Crown‐rump length (mm) (N = 426 missing) Mean (SD) 29.1 (8.9) 31.2 (9.3) 34.8 (11.3) 30.1 (9.3)
Season of measurement
Nov–May (dry) N (%) 78 (53.4) 86 (52.4) 82 (54.3) 75 (47.2)
Jun–Oct (rainy) N (%) 68 (46.6) 78 (47.6) 69 (45.7) 84 (52.8)
Maternal age (years) (N = 1 missing) Median (IQR) 30.0 (25.1, 35.0) 29.8 (24.1, 33.7) 29.8 (24.0, 33.4) 29.5 (24.3, 34.2)
Maternal weight (kg) (N = 1 missing) Mean (SD) 54.5 (7.7) 55.0 (9.7) 55.6 (8.7) 55.5 (9.8)
Maternal height (cm) (N = 2 missing) Mean (SD) 161.9 (6.0) 162.2 (5.6) 162.1 (5.8) 161.9 (5.8)
Maternal BMI (kg/m2) (N = 3 missing) Median (IQR) 20.6 (18.8, 22.4) 20.3 (18.7, 22.2) 20.5 (19.0, 22.5) 20.6 (19.2, 22.2)
Parity (N = 10 missing)
0 N (%) 14 (9.7) 18 (11.2) 14 (9.4) 12 (7.7)
1–3 N (%) 39 (26.9) 56 (34.8) 54 (36.2) 52 (33.6)
4–12 N (%) 92 (63.5) 87 (54.0) 81 (54.4) 91 (58.7)
BMI = body mass index; FeFol = iron and folic acid; IQR = inter‐quartile range; LNS = lipid‐based nutritional supplement; MMN = multiple‐micronutrient;
PE = protein‐energy; SD = standard deviation.
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This study conducted a post‐hoc analysis in a prenatal trial of nutri-
tional supplementation in rural Gambia. Despite evidence of
between‐arm differences in some fetal biometry measures, likely due
to higher values in the PE group, z‐scores at birth were not greater in
the intervention arms than the FeFol arm. Our key finding, therefore,
is that prenatal LNS intervention was not associated with better fetal
growth in the whole sample. Pronounced seasonality in The Gambia
affects many aspects of diet, health, and behavior (Moore, 2016),
thereby providing a robust design to explore how efficacy within a sin-
gle population might vary depending on nutritional status. In sub‐group
analyses, evidence was found to suggest that the supplements were
more efficacious in the dry season than the rainy season (for some fetal
biometry outcomes at 30 weeks of gestation) and among mothers who
demonstrated the greatest gestational weight gain (for some neonatal
anthropometry outcomes). These results, however, need to be
interpreted with caution given that the study was not prospectively
designed to test for such association modification.
The finding that both PE and/or MMN supplementation were sig-
nificantly associated with increased birth weight, albeit only in a sub‐
group, is in agreement with the most recent Cochrane reviews (Haider
& Bhutta, 2015; Ota et al., 2015). Existing evidence also supports our
finding that MMN supplementation was associated with increased
birth weight only in well‐nourished women (as indicated by better ges-
tational weight gain; Haider & Bhutta, 2015; Fall, Fisher, Osmond,
Maternal, & Micronutrient, 2009). However, the existing evidence
showing that PE supplementation is more effective in undernourished
women is opposite to our finding that PE supplementation was associ-
ated with increased birth weight only in well‐nourished women (as
indicated by better gestational weight gain; Imdad & Bhutta, 2012). It
may be that the sub‐group of women in the present study, in which
significant associations were observed, was macronutrient deficient
(thereby increasing the efficacy of PE supplementation) but not micro-
nutrient deficient (thereby increasing the efficacy of MMN supplemen-
tation). This proposition ties in somewhat with the observation that
women in the highest quartile of gestational weight gain actually
weighed about 6 kg less at booking than women in the lowest quartile,
and it was not until 30 weeks of gestation that the two groups
weighed approximately the same (59.4 vs. 60.8 kg).
LNS products are a relatively recent development, and as such,
few prenatal trials have been completed and published. The results
so far have been equivocal with no evidence of a positive effect on
birth size in Malawi (Ashorn et al., 2015), some evidence among
younger women and those with household food insecurity in Bangla-
desh (Mridha et al., 2016), some evidence among primiparous women
in Ghana (Adu‐Afarwuah et al., 2015), and some evidence in Burkina
Faso but only for length and only among births occurring at the end
of the rainy season (Huybregts et al., 2009; Toe et al., 2015). The
sub‐group association of LNS supplementation with birth weight in
the present study but not in Burkina Faso could be explained by
the higher daily energy dose provided by the LNS product used in
The Gambia (746 vs. 372 kcal/day) and by the fact that the control
group in Burkina Faso also received MMN, which are known to
T
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increase birth weight. The association of LNS supplementation with
birth length in Burkina Faso but not in The Gambia was surprising,
particularly given that we supplemented at two times the UNICEF/
WHO/United Nations University formulation of key micronutrients,
while in Burkina Faso, they only supplemented at one times the for-
mulation. It may be that the Gambians were more micronutrient defi-
cient or that the Burkinabes had a lower threshold for the
intervention to work because stunting is more prevalent in Burkina
Faso than The Gambia (UNICEF‐WHO‐The World Bank, 2015). For
policy‐makers, such inconsistent results between trials means that
the scale‐up of antenatal LNS‐based supplements for SGA rate
reduction may not yet be justified.
The ability to gain weight during gestation is seasonally patterned
in The Gambia (Poppitt et al., 1994), so it makes sense that we
observed association modification by both season and gestational
weight gain. Taken together, our interpretation of the association mod-
ification results is that environments conducive to better gestational
weight gain (i.e., the dry season) may allow the mother to be more
nutritionally replete, such that any additional nutrients from supple-
mentation can be used to support fetal growth and development. This
reflects a classic trade‐off scenario between optimization of maternal
nutritional status and fetal growth and development that has been
reported on previously (Rasmussen & Habicht, 2010; Lechtig,
Yarbrough, Delgado, Habicht, & Klein, 1975). Previous trials in The
Gambia and other countries with marked seasonality have found
stronger positive effects of supplementation for births occurring in
the nutritionally debilitating rainy season (Toe et al., 2015; Ceesay
et al., 1997). This finding, however, is not mutually exclusive from
the findings of the present study as 43% of women in the highest quar-
tile of gestational weight gain (in whom the intervention seemed to
work) actually went on to deliver in the rainy season, compared to just
25% of women in the lowest quartile of gestational weight gain.
One unexpected finding was that differences in fetal biometry
were likely due to higher values in the PE arm compared to the
PE + MMN arm. This was more likely due to baseline differences in
fetal size at booking (BPD 30.2 vs. 28.5 mm) persisting to 20 and
30 weeks of gestation than differential compliance between the two
LNS arms (81.7% vs. 81.2%, respectively). The fetal biometry results,
therefore, have to be interpreted with caution, particularly given that
we did not observe any between‐arm differences in weight, length,
or HC at birth in the whole sample.
The main strengths of the present study are that (a) supplementa-
tion started early in gestation (~13 weeks), which is important knowing
that even pre‐conceptional nutritional status may impact on birth
weight (Potdar et al., 2014; Young et al., 2015); and that (b) fetal biom-
etry as well as neonatal anthropometry measures were available and
analyzed, thereby providing us with the opportunity to investigate
the ages in development when the supplements might have first
started to affect growth. In terms of limitations, this was a post‐hoc
analysis with a sample size that was not powered on the outcomes
presented in this paper or for the sub‐group analyses. Average power
to detect an intervention association with an outcome in our final
regression models (Table 4) was 0.48, so we had a relatively high risk
of rejecting false null hypotheses (i.e., type two errors). The fact that
we generally found consistent association modification across theTA
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different measures (e.g., birth weight, HC, and WFL) by variables that
we know are related to each other in The Gambia (i.e., season and ges-
tational weight gain) suggests, however, that these key findings are not
chance. Nonetheless, further research is needed to confirm our find-
ings and reveal which components or casual factors of maternal weight
gain may increase the efficacy of prenatal nutritional intervention.
Other limitations include not having a maternal weight measure at
the very end of gestation, which would have allowed us to quantify
weight gain throughout the final trimester, and not necessarily being
able to generalize our results to other populations.
In conclusion, the present paper found no strong evidence that a
prenatal LNS intervention was associated with better fetal growth in
the whole sample. Sub‐group analyses did, however, reveal positive
and significant associations of all interventions (i.e., MMN, PE, or
MMN + PE vs. FeFol) with birth weight and HC among women who
demonstrated the greatest gestational weight gain.
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